Ad-Tech Medical Instrument

Ad-Tech Medical Instrument

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $9.2M

Overview

Ad-Tech Medical Instrument is a long-established, privately-held medical device company focused on developing and commercializing specialized intracranial electrodes for the diagnosis and surgical treatment of neurological diseases, primarily epilepsy. Founded in 1983 by a parent affected by neurological disease, the company has built a strong reputation for its proprietary electrode designs, including subdural grids/strips, depth electrodes, and related surgical accessories. In a significant strategic development, Ad-Tech was acquired by Nihon Kohden, a major Japanese medical electronics firm, a move aimed at solidifying comprehensive epilepsy diagnostics and care offerings globally.

EpilepsyNeurological Disorders

Technology Platform

Proprietary designs for intracranial electrodes (subdural grids/strips, depth electrodes, foramen ovale electrodes) and unique connection systems for long-term EEG monitoring, brain mapping, SEEG, and brain stimulation.

Funding History

2
Total raised:$9.2M
Series A$8M
Seed$1.2M

Opportunities

The acquisition by Nihon Kohden opens vast global distribution channels and enables deep integration of Ad-Tech's electrodes with leading neuromonitoring and diagnostic systems, creating a comprehensive epilepsy care solution.
Expanding applications of invasive monitoring into brain-computer interface research and other neurological disorders present significant adjacent market growth potential.

Risk Factors

The company faces integration risks following its acquisition, potential long-term disruption from alternative non-invasive monitoring technologies, and dependence on reimbursement policies for complex epilepsy surgery procedures.
Regulatory changes in key markets like the US and EU also pose ongoing compliance challenges.

Competitive Landscape

Ad-Tech competes in the specialized niche of intracranial electrodes with other private medtech firms like PMT Corporation and Integra LifeSciences (which offers related neurosurgery tools). Its primary competitive advantage is its focused expertise and proprietary designs, now significantly bolstered by the backing and complementary technology portfolio of its parent company, Nihon Kohden, creating a more formidable integrated offering.